Beacon Pointe Advisors, LLC Organon & Co. Transaction History

Beacon Pointe Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $24,782 - $37,116	1,157 Added 14.42%	9,180 $215,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $37,016 - $45,432	-1,588 Reduced 16.52%	8,023 $224,000
Q3 2022 Nov 09, 2022	SELL	$23.4 - $34.25 $27,916 - $40,860	-1,193 Reduced 11.04%	9,611 $215,000
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $13,360 - $16,415	422 Added 4.06%	10,804 $362,000
Q1 2022 May 17, 2022	BUY	$30.45 - $39.36 $114,157 - $147,560	3,749 Added 56.52%	10,382 $363,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $42,689 - $55,286	-1,489 Reduced 18.33%	6,633 $202,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $232,532 - $289,468	8,122 New	8,122 $266,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.